Thoracentesis

Published on 08/04/2015 by admin

Filed under Emergency Medicine

Last modified 08/04/2015

Print this page

This article have been viewed 4276 times

Chapter 9

Thoracentesis

Erik H. Adler and Barbara K. Blok

Thoracentesis is a word derived from the Greek thorakos (chest) and kentesis (to pierce). Classically, this refers to any maneuver whereby a sharp object is inserted into the chest to make a conduit between the intrathoracic cavity and the atmosphere that allows air or fluid to exit. Clinically, thoracentesis refers to the removal of fluid from the pleural space for diagnostic or therapeutic purposes. This chapter concentrates on the identification and management of fluid accumulations in the chest of patients seen in the emergency department (ED).

Anatomy and Physiology of the Pleural Space

During embryologic development, the lung buds grow out of a median mass of mesenchymal tissue into the future thoracic cavities. This process results in the development of two linings: the visceral pleura, which wraps around the lungs, and the parietal pleura, which lines the inner surface of the thoracic cavities and meets the visceral pleura at the root of the lungs in the mediastinum. The space between the two linings is called the pleural space.

Understanding this basic anatomy is important because it underlines the similarities and differences between the two linings, which in turn determines the physiology and pathophysiology of the pleural space. Both the visceral and parietal pleurae are thin layers of connective tissue through which both fluid and protein can leak. Embedded in each membrane are capillary beds that generate both hydrostatic and oncotic pressure. The visceral pleura is supplied by the bronchial arteries and empties into the pulmonary veins, whereas the parietal pleura is supplied by the intercostal arteries and empties into the intercostal veins. In the healthy state there is a small net movement of fluid across the pleural and parietal capillary beds into the low-pressure pleural space. Over the course of a day, the lymphatic system maintains a minimum pleural space outflow of 0.01 mL/kg/hr, with a 30-fold capacity of 3 mL/kg/hr.1,2 Overall, in a healthy state a small amount of fluid, estimated at 0.26 mL/kg of body mass, is present in the pleural space at any given time.³

It is believed that in most instances, the development of a pleural effusion requires both an increase in fluid entry into the pleural space and a decrease in its removal.⁴

Etiology of Pleural Effusions

The most common causes of pleural effusion in adults are congestive heart failure (CHF), pneumonia, malignancy, pulmonary embolism (PE), and viral disease.4,5 The most common cause of pleural effusions in children is pneumonia, followed by congenital heart disease, malignancy, renal disease and trauma.⁶ Pleural effusions can be classified as either transudates or exudates. Distinguishing between transudates and exudates narrows the differential diagnosis and directs management and therapy. A comprehensive list of causes can be found in Box 9-1. The most common are discussed in the following sections.

Transudates: Overwhelming the System

Transudates are caused by either an increase in intravascular hydrostatic pressure or a decrease in intravascular oncotic pressure, which generates a net flow of fluid into the pleural space. These effusions are typically straw colored and serous with very low cellular and protein content.

The most common cause of a transudate is CHF. The increased hydrostatic pressure in patients with CHF results in a net flow of fluid into the pulmonary interstitium. This fluid readily moves across the leaky visceral pleura into the pleural space,⁷ and when the volume of fluid exceeds the capacity of the lymphatics for drainage, a pleural effusion develops. In addition, the elevated systemic hypertension associated with CHF also increases fluid flow across the parietal pleura and decreases lymphatic flow out of the thorax. Any process that results in compromised left ventricular outflow can result in a pleural effusion, including myocardial infarction, cardiomyopathy, and valvular disease.

Patients with cirrhosis are frequently hypoalbuminemic, which leads to a chronic state of decreased plasma oncotic pressure. The imbalance between the hydrostatic and oncotic forces across the pleural membrane results in an effusion.⁸ In addition, experiments have shown that high volumes of ascites can stretch the diaphragm enough to allow fluid to pass through preexisting microdefects.

Exudates: Pathology of Tissues, Destroying the System

Exudates are caused by pleural inflammation, increased pleural membrane permeability, or lymphatic obstruction. More than 90% of exudative effusions are due to malignancy, pneumonia, PE, and gastrointestinal diseases (e.g., pancreatitis, esophageal perforation).

The main mechanism of cancer-related pleural effusion is obstruction. Neoplasms can either damage functional lymphatic stomata in the parietal pleura or prevent outflow more distally via involvement of the mediastinal lymph nodes. Other mechanisms involving neoplasm include metastasis to the visceral pleura, increasing capillary permeability, and obstruction of the thoracic duct with consequent chylothorax.⁹

A pleural effusion associated with pneumonia (bacterial or viral) or a lung abscess is termed a parapneumonic effusion. In the first stage of a parapneumonic effusion, called the exudative stage, sterile fluid flows across the visceral pleura secondary to increased pulmonary interstitial fluid. When the infection and resultant inflammation continue unchecked, a simple uncomplicated parapneumonic effusion becomes complicated. This occurs initially by deposition of fibrin on the visceral and parietal pleurae, which results in loculations (the fibrinopurulent stage), and finally, by growth of fibroblasts along the pleural surfaces, which results in a tough peel that encases the lung (the organizational stage).

A pleural effusion develops in at least 30% of those with PE.¹⁰ Therefore, when the cause of the effusion is unclear, PE should be strongly considered. The effusions associated with PE are often too small to require thoracentesis, but recent studies have shown them to be uniformly exudative, probably resulting from ischemia- and infarction-induced increases in pulmonary capillary permeability.¹¹

Traumatic Effusions: Acute and Catastrophic Destruction of the System

Esophageal rupture can result from forceful vomiting, as in the case of Boerhaave’s syndrome, or from instrumentation, as in the case of endoscopy, Blakemore-Sengstaken tube placement, or rigid nasogastric tube placement. Hemothorax can result from sharp traumatic injuries, cannulation of the subclavian vein or artery, PE, aortic aneurysm, and supratherapeutic levels of anticoagulant. Chylothorax develops from acute disruption of the thoracic duct, usually in the setting of trauma or malignancy. These effusions are usually large-volume collections that accumulate over an extremely short period and rapidly compromise both oxygenation and the circulation.

Diagnosis of Pleural Effusion

Clinical Diagnosis

The three most common symptoms related to pleural effusions are chest pain, cough, and dyspnea. The chest pain may be of several types, depending on the underlying pathology. Chest pain solely from the fluid collection is often described as a “dull ache.” Pleuritic chest pain is more indicative of localized irritation of the parietal pleura, which has abundant nerve fibers. Because of innervation by the phrenic nerve, involvement of the mediastinal pleura results in chest pain with ipsilateral shoulder pain. Pain can often be referred to the abdomen also via innervation of the intercostals. Cough may be due to bronchial irritation from compression of the lung parenchyma.

Because pleural effusions result from a large list of disease processes, be sure to cover all systems in the history and physical examination of the patient while searching for clues to the underlying etiology. Perform the lung examination both as an evaluation of lung pathology and to determine the extent of the effusion. Large effusions can result in an increase in the size of the hemithorax, as well as bulging intercostal spaces on the side of the effusion. On palpation, tactile fremitus is either reduced or completely absent over the effusion because the fluid separates the lung from the thoracic wall and absorbs the vibrations from the lung. Percussion over the effusion produces a characteristic dullness, which shifts when the patient changes position if the fluid is free flowing. In general, auscultation reveals decreased to absent breath sounds, depending on the size of the effusion. Egophany can occasionally be appreciated at the superior border of the effusion as a result of underlying atelectatic lung tissue. Pleural rubs may be appreciated if pleural irritation is present, but they are often difficult to auscultate until after evacuation of fluid. Palpation, percussion, auscultation, and bedside ultrasound (US) are all useful in determining the upper extent of the effusion.

Radiologic Diagnosis

Chest Radiograph

Because pleural fluid is denser than air-filled lung, a free-flowing effusion will first accumulate in the most dependent parts of the thoracic cavity, the subpulmonic space and the lateral costophrenic sulcus. Pleural effusions are usually visible on an upright posteroanterior chest radiograph if 200 to 250 mL of fluid is present. A lateral radiograph may reveal an effusion of 50 to 75 mL.

The earliest recognized sign of a pleural effusion on an upright chest radiograph is blunting of the lateral costophrenic angle, which may be seen on either the frontal or the lateral view (Fig. 9-1). With larger free-flowing effusions, the pleural fluid appears as a meniscus that curves downward toward the mediastinum in the frontal view and appears “lowest” midway through the thoracic cavity on the lateral view (Fig. 9-2). The true height of an effusion corresponds to the highest portion of the meniscus. The presence of a pneumothorax or abscess may alter the appearance of the meniscus to more of a straight line (air-fluid level).

Figure 9-1 Posteroanterior upright chest radiograph indicating a moderate pleural effusion with a bilateral meniscus at the costophrenic angles. The pleural effusion has a curvilinear upper margin concave to the lung and is higher laterally than medially.

Figure 9-2 Left-sided pleural effusion seen on posteroanterior (A) and lateral (B) radiographs. The meniscus can be visualized on both views (arrows). The meniscus is the highest point of the effusion for thoracentesis purposes.

Occasionally, up to 1000 mL of fluid can collect in the subpulmonic space and cause neither blunting of the costophrenic angles nor a meniscus appearance on the upright radiograph. This is called a subpulmonic effusion (Fig. 9-3) and should be suspected if the hemidiaphragm is elevated and the dome peaks more laterally than expected on the anteroposterior radiograph.

Figure 9-3 Right-sided subpulmonary pleural effusion. On erect posteroanterior (A) and lateral (B) radiographs, the effusion simulates a high hemidiaphragm. It is also seen with ultrasound (C) and computed tomography (D).

Pleural effusions are more challenging to identify on a chest radiograph in a supine patient. If the effusion is large enough, a diffuse haziness may be appreciated (Fig. 9-4). Other findings include apical capping, obliteration of the hemidiaphragm, partial opacification of a hemithorax, and a widened minor fissure.

Figure 9-4 A, Supine radiograph of a patient with a large pleural effusion. Note the generalized homogeneous (“ground glass”) increase in radiopacity of the right side of this patient because of posterior layering of a pleural effusion. Also note the difference in the appearance of the pleural effusion when the patient is supine. As opposed to the upright radiograph (see Fig. 9-2), there is minimal blunting of the costophrenic angles and the vascular opacities are preserved in the overlying lung. B, A chest computed tomography (CT) scan of the same patient confirms the presence of a right-sided pleural effusion. Note the typical sickle-shaped appearance of the effusion on CT.

Obtain bilateral decubitus radiographs when a pleural effusion is seen or suspected. With the side of the effusion down, a simple pleural effusion will follow gravity and layer between the floating lung and the chest wall (Fig. 9-5). Unusual shapes reflect the presence of loculations, contained abscesses, or masses. A lateral decubitus view on the opposite side draws the fluid toward the mediastinum and allows visualization of the lung parenchyma to determine whether infiltrates or masses are present.

Figure 9-5 Left lateral decubitus chest radiograph demonstrating the presence of free pleural fluid. The amount of pleural fluid can be semiquantified by measuring the distance between the two arrows. Thoracentesis may be difficult to perform if the fluid distance is less than 1 cm on the lateral decubitus radiograph. This view may also differentiate simple effusions from loculated effusions.

With diseased or scarred lung, tissue adhesions can trap pleural fluid within the parietal, visceral, or interlobar surfaces. Because these adhesions anchor the fluid collection, loculated effusions are often described as “D-shaped” (Fig. 9-6). Fluid loculated in the fissures assumes a lenticular shape.

Figure 9-6 Loculated pleural effusion. A, A posteroanterior radiograph demonstrates the D-shaped appearance of a right-sided loculated pleural effusion (arrows) in the midchest region. B, Occasionally, pleural effusions (arrows) may become loculated in the fissures.

In the case of a massive pleural effusion, the entire hemithorax is opacified (Fig. 9-7). On such films, identification of mediastinal shift is a key to identifying the underlying process. In the absence of a diseased lung or mediastinum, large fluid accumulations push the mediastinum contralaterally. When the mediastinum is shifted toward the effusion, the lungs and main stem bronchi are diseased or obstructed (or both). When the mediastinum is fixed midline, it is likely that it is invaded by a tumor.^12,13 As discussed later, differentiation of these disease processes is best done with computed tomography (CT). CHF often produces bilateral pleural effusions, which is generally first evident on the right side (Fig. 9-8).

Figure 9-7 Massive pleural effusion before (A) and after (B) thoracentesis. Notice the underlying mass that is seen following thoracentesis. A computed tomography scan would have prospectively confirmed this radiograph.

Figure 9-8 Effusion from congestive heart failure. A, A frontal chest radiograph in a patient with pulmonary edema shows cardiomegaly, bilateral pleural effusions (arrows), and central interstitial thickening, including Kerley’s A lines. Note that the right effusion is slightly larger than the left effusion. B, High-resolution computed tomography scan in a patient with pulmonary edema shows interstitial edema with bilateral, basilar, centrilobular ground-glass opacity nodules (arrowheads) and smooth interlobular septal thickening (arrow). Bilateral pleural effusions are also present. (Courtesy of Michael B. Gotway, MD, Department of Radiology, University of California, San Francisco.)

CT

Although thoracentesis is usually performed on the basis of findings on plain radiography, CT is more sensitive than plain films in detecting very small effusions and can readily assess the extent, number, and location of loculated pleural effusions. Loculated lesions can appear vague on plain films. In the distinct anatomic relationships shown on cross-sectional CT views, free-flowing pleural fluid will form a sickle shape in the most dependent regions (see Fig. 9-4), whereas loculated fluid collections will remain lenticular and relatively fixed in space. In addition, CT can be used to assess pleural thickening, irregularities, and masses that are suggestive of malignancy and other diseases that result in exudative effusions. With intravenous contrast dye, CT differentiates lung parenchymal disease, such as a lung abscess. Pulmonary emboli can also be detected with the use of intravenous contrast enhancement. CT is also useful in identifying mediastinal pathology and in differentiating ascites from loculated subpulmonic pleural fluid.

Ultrasound

There are definite advantages to using US for assessment of pleural effusions as well. In particular, it is easy and noninvasive and can be performed at the bedside. US is superior to chest radiographs in diagnosing effusions 14–16 and can detect effusions as small as 5 mL.¹⁷ Although some details can be seen only with CT, US can identify fluid loculations, separate fluid from pleural thickening, and distinguish solid from fluid pleural lesions. US can also be used to identify both pulmonic and abdominal causes of the pleural effusion (Fig. 9-9). Furthermore, US is a useful bedside tool when performing thoracentesis because it allows rapid identification of both the diaphragmatic location and the intercostal level that correlates with the superior margin of the effusion.

Figure 9-9 Ultrasound image of a patient with a large right-sided pleural effusion. Note the dark appearance of the pleural effusion with a free-floating lung. Ultrasound is also useful for identifying the diaphragm (right of the screen) and the top of the effusion (left of the screen). Ultrasound can be used during the procedure itself if a sterile probe cover is used, which enables the operator to view the tip of the needle entering the effusion and to avoid vital structures, such as the lung or diaphragm. (From Thomsen T, Setnik G, eds. Procedures Consult—Emergency Medicine Module. Copyright 2008 Elsevier Inc. All rights reserved.)

Indications

Diagnostic Thoracentesis

During diagnostic thoracentesis, a sample of pleural fluid is obtained to evaluate the cause of a pleural effusion. It requires the removal of 50 to 100 mL of pleural fluid for laboratory studies. Most new effusions that measure greater than 10 mm on a decubitus radiograph, CT, or US require diagnostic thoracentesis. An exception would be a new pleural effusion with a clear clinical diagnosis (e.g., CHF) and no evidence of a superimposed pleural space infection.

Therapeutic Thoracentesis

The usual goal of therapeutic thoracentesis is to help relieve the dyspnea associated with a large pleural effusion and typically requires removing a much larger volume of pleural fluid.

Contraindications

There are no absolute contraindications to thoracentesis. Recent studies indicate that if performed under real-time US guidance, thoracentesis is safe despite abnormal coagulation parameters.¹⁸ Closely watch all patients with coagulation abnormalities, including those with renal failure, for signs of bleeding after the procedure. Avoid skin puncture through a site of cellulitis or herpes zoster by choosing an alternative insertion site or patient position. Use real-time US guidance when performing thoracentesis on patients who are undergoing mechanical or manual ventilation because the positive pressure associated with mechanical ventilation may place the patient at increased risk for the development of a pneumothorax.